Renesas Electronics has introduced all-in-one solutions for managing lithium-ion battery packs in a wide range of ...

Bristol Myers Squibb (BMS) has agreed to acquire its longtime cell therapy partner 2seventy bio in a deal valued at $286m. Announced after markets closed on 10 March, the $5-per-share offer represents ...

BMS is paying $150 million upfront in cash and equity to kick off the alliance with another $3 billion in additional payments that will be forthcoming if the projects advance as hoped.

Abecma made $406 million in 2024, of which BMS paid $43 million to 2seventy bio as part of their profit-sharing agreement.

More than a year into a strategic pivot to zero in on the multiple myeloma cell therapy Abecma, 2seventy bio is selling itself to partner Bristol Myers Squibb. Bristol Myers has agreed to buy out ...

Marelli is bringing one of the most powerful tools for lab-testing EV batteries—electrochemical impedance spectroscopy (EIS)—under the hood. Details on a BMS based on electrochemical impedance ...

Bristol Myers Squibb (BMS) has agreed to acquire its longtime cell therapy partner 2seventy bio in a deal valued at $286m. Announced after markets closed on 10 March, the $5-per-share offer ...